Latest return on equity
Lyell Immunopharma Return on equity
Direct answer
Lyell Immunopharma's return on equity is -93.28%.
The verified market snapshot reports -93.28%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 8, 2026.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -93.28%
Explore related company data
View Lyell Immunopharma's market capitalizationView Lyell Immunopharma's price-to-book ratioView Lyell Immunopharma's 52-week price rangeView Lyell Immunopharma's revenue growthView Lyell Immunopharma's profit marginView Lyell Immunopharma's debt-to-equity ratioView all Lyell Immunopharma key metricsReturn to Lyell Immunopharma profile